Revenue | ₹0.15Cr |
Net Profits | ₹0.17Cr |
Net Profit Margins | 113.33% |
Chemo Pharma Laboratories Ltd’s revenue fell -121.43% since last year same period to ₹0.15Cr in the Q3 2024-2025. On a quarterly growth basis, Chemo Pharma Laboratories Ltd has generated -123.81% fall in its revenue since last 3-months.
Chemo Pharma Laboratories Ltd’s net profit fell -125% since last year same period to ₹0.17Cr in the Q3 2024-2025. On a quarterly growth basis, Chemo Pharma Laboratories Ltd has generated -127.87% fall in its net profits since last 3-months.
Chemo Pharma Laboratories Ltd’s net profit margin jumped 16.67% since last year same period to 113.33% in the Q3 2024-2025. On a quarterly growth basis, Chemo Pharma Laboratories Ltd has generated 17.05% jump in its net profit margins since last 3-months.
The revenue for Chemo Pharma Laboratories Ltd in the Q3 results 2024 was ₹0.15Cr.
The net profit for Chemo Pharma Laboratories Ltd in the Q3 results 2024 was ₹0.17Cr.
The net profit margin for Chemo Pharma Laboratories Ltd in the Q3 results 2024 was 113.33%.
The revenue for Chemo Pharma Laboratories Ltd in the Q3 results 2023 was ₹0.70Cr.
The net profit for Chemo Pharma Laboratories Ltd in the Q3 results 2023 was ₹0.68Cr.
The net profit margin for Chemo Pharma Laboratories Ltd in the Q3 results 2023 was 97.14%.